STOCKHOLDERS’ EQUITY (Tables)

9 Months Ended

Nov. 30, 2018

Equity [Abstract]

Schedule of Stock-based Compensation Expense

Stock-based compensation expense is included in the following captions of the condensed consolidated statements of comprehensive income (loss) (in thousands):

	Three Months Ended				Nine Months Ended
	November 30,				November 30,
	2018		2017		2018		2017
Cost of revenues	$	251	$	198	$	640	$	477
Research and development		538		427		1,323		1,045
Selling and marketing		808		677		2,059		1,610
General and administrative		1,344		1,318		4,066		3,532
	$	2,941	$	2,620	$	8,088	$	6,664

Summary of Stock Option Activity

Changes in our outstanding stock options during the nine months ended November 30, 2018 were as follows (options in thousands):

	Number of Options			Weighted Average Exercise Price		Weighted average remaining contractual life (years)		Aggregate intrinsic value
Outstanding at February 28, 2018		980		$	11.29		5.9
Granted		140			23.08
Exercised		(66	)		1.87
Forfeited or expired		—			—
Outstanding at November 30, 2018		1,054		$	13.44		6.1	$	5,501
Exercisable at November 30, 2018		672		$	9.98		4.5	$	5,223

Summary of Restricted Stock Shares (RSU's), and Performance Stock Units (PSU's) Activity

Changes in our outstanding restricted stock shares, performance stock units (“PSUs”) and restricted stock units (“RSUs”) during the nine months ended November 30, 2018 were as follows (restricted shares, PSUs and RSUs in thousands):

	Number of Restricted Shares, PSUs and RSUs			Weighted Average Grant Date Fair Value		Shares Retained to Cover Statutory Minimum Withholding Taxes
Outstanding at February 28, 2018		1,434		$	17.72
Granted		714			22.81
Vested		(461	)		17.28		156
Forfeited		(161	)		19.45
Outstanding at November 30, 2018		1,526		$	20.05